Is MS stock a buy after today's 3.1% rebound?

Is MS worth buying right now? That depends on your goals and timeline, and we don't make that call for anyone. What we can do is lay out the evidence investors usually weigh. Of 33 Wall Street analysts covering MS, 20 rate it a buy, 12 a hold and 1 a sell — a consensus of Buy.

Below, we look at where the stock trades today, what Wall Street analysts think, how the valuation compares with similar companies and what the company's insiders have been doing with their own shares.

The chart below tracks MS's daily closing price from May 13, 2026 to Nov. 6, 2026. Over that stretch it is down 5.3%, from $191.58 to $181.44, with a high of $225.90 on July 15, 2026 and a low of $177.36 on Oct. 19, 2026. Each red circle marks a week in which company insiders sold shares on the open market (2 weeks in this period; bigger circles mean more money). There are no green diamonds: no insider bought on the open market in this window.

Where MS trades today

$181.44 at the Nov. 6, 2026 close: 19.7% from the 52-week high of $225.9 and 19.5% above the 52-week low of $151.78. One month: -2.6%; three months: -15.2%.

What analysts say about MS

Of 33 Wall Street analysts covering MS, 20 rate it a buy, 12 a hold and 1 a sell — a consensus of Buy. Ratings are little changed over three months.

MS valuation in one line

MS trades at a P/E of 14.4, 3.54× sales, revenue +16.2% year over year (latest quarter Sep 2026).

Also worth knowing about MS

Live MS data, updated every 30 minutes: MS insider trades, ownership and filings →

What would change the picture for MS

These are the specific events and levels to watch. None of them is a prediction.

• The Jan. 14, 2027 earnings report (66 days away). Morgan Stanley beat estimates in all 4 of the last 4 quarters (average surprise +8.2%); a miss would break that pattern.
• An open-market purchase by an insider at Morgan Stanley. There has been none in 90 days; Form 4 filings would show one within two business days of the trade.
• Analyst ratings: the average score moved from 3.81 to 3.79 over three months (on a scale where 5 is strong buy and 1 is strong sell). A run of downgrades after earnings usually shows up here first.
• Price levels: a close above $225.9 would be a new 52-week high, 24.5% above the latest close of $181.44; a close below $151.78 would be a new 52-week low, 16.3% below it.
• Growth: revenue rose 16.2% year over year in the quarter ending Sep 2026 (trend: steady). At a P/E of 14.4, a slowdown would matter more than at a lower multiple.
• New shares: dilution risk is moderate now. A new shelf registration (S-3) or a prospectus supplement (424B) for an offering would raise it.

How MS compares with its peers

Over the past month MS ranks 4 of 6 in this group (-2.6%); the best was WFC (+2.9%) and the weakest BAC (-7.8%).

MS's P/E of 14.4 is above the peers' median of 12.5, so investors pay more for each dollar of its profit, usually for faster expected growth.

MS history: what happened after similar moves

Since 2023, MS fell 10% or more in a month 5 times (separate episodes, not counting the current one). Three months later it was higher in 4 of 4 cases; the median change was +24.8%.

Past moves don't predict the next one; they show how volatile the stock has been.

Questions people also ask

What is MS's 52-week high and low?

Over the past year MS closed as high as $225.9 and as low as $151.78. At $181.44 (Nov. 6, 2026) it is down 19.7% from the high and 19.5% above the low.

When does Morgan Stanley report earnings next?

The next report is expected on Jan. 14, 2027, 66 days from now. Morgan Stanley beat the average estimate in all 4 of the last 4 reports.

Is Morgan Stanley issuing new shares?

Dilution risk reads moderate (35/100); the share count fell 1.7% in a year. That is based on 2 offering-related filing(s) in 12 months.

Does MS pay a dividend?

Yes: $4.15 per share over the last 12 months, about 2.29% at today's price.

Are MS insiders buying or selling?

No Morgan Stanley insider bought or sold MS on the open market in the last 90 days, according to SEC Form 4 filings.

Is Morgan Stanley profitable?

Yes. Morgan Stanley had $80.2 billion of revenue over the last 12 months with a net margin of 25.5% and a P/E of 14.4.

Dates to watch for MS

Insider trades can come any day: they must be filed on Form 4 within two business days.

Key terms on this page

P/E ratio

Price divided by the last 12 months of earnings per share. A P/E of 20 means investors pay $20 for each $1 of yearly profit. It is only defined when the company is profitable.

Price-to-sales

Market value divided by the last 12 months of revenue. Useful for companies with little or no profit, but it ignores margins.

Form 4

The SEC form a company's officers, directors and 10% owners must file within two business days of buying or selling its stock.

Open-market trade

A purchase or sale on the exchange at the market price, paid with the insider's own money (code P or S on Form 4), as opposed to option exercises, grants or gifts.

Dilution

When a company issues new shares, each existing share owns a smaller piece of the company. Common sources: stock offerings, convertible debt and large stock-based pay.

52-week high / low

The highest and lowest daily closing price over the past year (about 252 trading days).

Analyst consensus

The average of Wall Street analysts' ratings (strong buy to strong sell). Analysts skew positive, so a hold is often read as a cautious view.

Where these numbers come from

Every number on this page is computed from the data when the page is refreshed (usually daily); nothing is typed in by hand. This is information, not investment advice.

• Price: daily closing prices through Nov. 6, 2026; changes use 5, 21 and 63 trading days; the 52-week range uses the last 252 closes.
• Insider trades: SEC Form 4 filings for the last 90 days, counting only open-market purchases (code P) and sales (code S); option exercises, grants, gifts and filings with data errors are left out.
• Analyst ratings: counts of current ratings from 33 analysts, compared with three months ago.
• Earnings dates and estimates: a market-data calendar; reported vs expected EPS for the last 4 quarters.
• Valuation and growth: revenue, earnings, margins and share counts from the company's SEC filings (XBRL data, latest quarter Sep 2026); P/E and price/sales use the latest close.
• Fund ownership: SEC Form 13F filings for Q2 2026.
• Dilution: share-count changes and offering-related SEC filings (shelf registrations, prospectus supplements, convertible notes) over two years, scored 0-100.
• History: 21-trading-day moves over about three years of daily closes, counted once per episode.